Edition:
United Kingdom

Alexion Pharmaceuticals Inc (ALXN.OQ)

ALXN.OQ on NASDAQ Stock Exchange Global Select Market

115.64USD
8:16pm GMT
Change (% chg)

$0.99 (+0.86%)
Prev Close
$114.65
Open
$115.96
Day's High
$117.09
Day's Low
$113.28
Volume
293,474
Avg. Vol
549,374
52-wk High
$140.76
52-wk Low
$102.21

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

David Brennan

64 2017 independent Chairman of the Board

Ludwig Hantson

55 2017 Chief Executive Officer, Director

Paul Clancy

56 2017 Chief Financial Officer, Executive Vice President

Brian Goff

49 2017 Chief Commercial Officer&Executive Vice President

Felix Baker

49 2015 Independent Director